Hologic Inc (WBO:HOLX)
€ 75.5 0 (0%) Market Cap: 17.00 Bil Enterprise Value: 17.31 Bil PE Ratio: 23.72 PB Ratio: 3.57 GF Score: 85/100

Hologic Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 09:30PM GMT
Release Date Price: €75.37 (+0.37%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

All right. Great. Thank you for joining us, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce Hologic. We have joined here with our CFO, Karleen Oberton; and CEO, Steve MacMillan. They'll give a short presentation followed by a Q&A session afterwards, where you can ask a question by raising your hand or submitting one via the webcast link. So with that, here's Steve.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Thank you, Casey, for having us, and good afternoon, everyone. Purpose-driven and results-driven, that pretty much captures what the Hologic team is all about. And as I rewind, 3 years ago, we stood up here, and I was very excited at that point in time because we had just said to our employee base that as we entered 2020, all the hard work we've done over the previous few years was going to become so evident to the outside world.

And we said that Hologic was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot